SUI DeSci Agents launches platform to democratize longevity amid DeSci boom

admin3 days ago

Dubai, United Arab Emirates, December 31, 2024, Chainwire

Decentralized Science (DeSci) aims to address systemic inefficiencies in traditional scientific research, including bureaucratic funding processes, underfunded breakthrough opportunities, and limited retail access to longevity investments.

SUI Desci Agents, a platform that helps retail customers invest in longevity research innovations, is poised to become a leading project at the forefront of upcoming trends.

BIO Protocol Listed on Binance

On December 23, 2024, Binance posted a tweet announcing the launch of Launchpool for the BIO protocol.

Users can now stake BNB and FDUSD to earn BIO airdrops over 10 days, and the listing of the BIO protocol on Binance is scheduled for January 3, 2025.

SUI DeSci Agents on the Front Line of DeSci

SUI Desci Agents is a platform for launching DeSci assets, automatically growing audiences through AI agents, and generating liquidity with mechanisms inspired by Pump.fun. We aim to democratize access to longevity research investments for retail users.

$DESCI provides a variety of features that make your project unique.

Tokenized Compounds: Users can review scientific data and statistics to bet on the potential of longevity compounds such as Epitalon and Rapamycin (the first compounds released).
Pluggable AI Agents: LLM-trained AI agents are paired with longevity compounds and promote them 24/7 across social platforms to ensure efficient outreach.
Layer 2 Liquidity Mechanism: Combining the $DESCI token with Compound creates a powerful liquidity ecosystem tailored to DeSci.
AI-powered B2C products: Wellness tools attract millions of health enthusiasts, driving organic growth and supporting the ecosystem.

The number of DeSci supporters continues to grow.

The number of DeSci supporters continues to grow and includes prominent web3 leaders and large web2 VC firms.

Vitalik Buterin highlighted the innovative potential of the DeSci project at the recent Devcon event.
Coinbase founder Brian Armstrong supports ResearchHub to drive open scientific collaboration.
A16Z led the $5 million funding round for AminoChain, a decentralized biosample marketplace.
Pfizer Ventures participated in a $4.1 million funding round for VitaDAO, a project focused on raising funds for research to extend human lifespan.

2025: The Year of $DeSci

In November 2024, Pump.Science launched two tokens, Rifampicin and Urolithin A, which subsequently attracted attention in the market. Their market capitalizations reached approximately $125 million and $45 million, respectively, within a few days of launch.

The decentralized science (DeSci) sector continues to expand, with SUI DeSci Agents establishing itself as a potential leader. The project is developing a platform that will allow retail customers to invest in tokenized long-lived compounds. They are also developing an AI-based B2C wellness tool that will help SUI Desci Agents onboard more users into the ecosystem.

With growing interest in decentralized approaches to science, $DESCI aims to contribute to the evolution of scientific innovation.

SUI DeSci Agent Information

SUI DeSci Agents is a platform designed to launch DeSci assets, grow your audience through AI agents, and create liquidity through advanced mechanisms inspired by Pump.fun.

Through the popular ticker $DeSci, the project aims to democratize access to long-lived research investments and empower retail audiences to actively engage in scientific advancement.